Седафитон may assist with maintaining functional stability during conditions involving episodic or fluctuating manifestations of mild stress and difficulty falling asleep. It is applied in addressing symptoms related to heightened physiological activity (such as restlessness) and symptoms that interfere with daily functioning (such as poor sleep quality).

The therapeutic use of the formulation is commonly intended to help with easing symptoms related to mild mental stress and supporting sleep. This therapeutic use is relevant for easing symptoms associated with restlessness, mild stress, and difficulty falling asleep.

Quick Fact: Supportive care for mild symptoms of mental stress

This therapeutic domain is considered relevant when supportive symptom management is appropriate in settings marked by temporary physiological imbalance. The overall formulation is applied across domains where additional symptomatic support is needed, primarily helping address symptom clusters that may become intense or disruptive during periods of mild unrest. This supportive role contributes to improved comfort during symptomatic phases and supports patients by easing the overall symptom burden in conditions marked by increased physiological stress.

The medicine is intended for the temporary relief of mild symptoms of mental stress and to aid sleep.

Who Can and Cannot Use Седафітон (Sedafiton) — Official Regulatory Information

Eligibility for Седафітон is determined by strict criteria regarding age, underlying medical conditions, and physiological status, as defined in the official regulatory documentation.

Who Must Not Use Седафітон (Contraindications)

Use of Седафітон is absolutely prohibited (contraindicated) for several patient groups:

• Individuals with a known hypersensitivity or allergy to any of the drug's components.
• Patients diagnosed with expressed arterial hypotension (severe low blood pressure) or expressed bradycardia (severe slow heart rate).
• Patients with depression or any other condition that causes suppression of the Central Nervous System (CNS) activity.
• Children under 12 years of age.

Age and Special Populations

Category	Regulatory Status
Eligible Age Group	Approved for individuals aged 12 years and older (adolescents and adults).
Pregnancy and Lactation	Not recommended due to officially stated insufficient safety data for use during pregnancy or breastfeeding.
Occupational Restriction	Use is limited for those who need to drive vehicles or operate potentially hazardous mechanisms, as these activities must be avoided during treatment.

Interactions with other medicines and products

This section summarizes the officially documented interaction profile of Седафитон (Valerian, Motherwort, and Hawthorn extracts) as defined in authoritative government regulatory sources.

---

Interaction Scope

Category	Official Regulatory Statement
Medicinal product categories with documented interactions	Medicinal products that cause Central Nervous System (CNS) depression, including sedatives, hypnotics, and anxiolytics.
Specific interacting medicines (if explicitly listed)	The regulatory documentation explicitly specifies Alcohol (ethanol) and other sedating herbal products or supplements (such as Kava or St. John's Wort) as interacting agents.
Mechanistic basis of interactions (only if stated in label)	The interaction is classified as pharmacodynamic, resulting in additive (reinforcing) sedative effects. No specific pharmacokinetic (CYP or transporter) interactions are officially documented as clinically relevant.
Timing-based interaction rules (if applicable)	No mandatory time separation requirements (e.g., "administer X hours apart") are specified in the official regulatory label.
Population-specific interaction notes (if applicable)	None explicitly stated to alter interaction severity in specific populations.

---

Interaction Classifications (High-Level)

Category	Official Regulatory Statement
Interaction severity classification	Interactions are classified as clinically significant due to the potential for pharmacodynamic reinforcement.
Interaction-context constraints	No substance is designated as a formal contraindication; the interaction is a use-with-caution scenario based on additive sedative effects.

---

Resulting Interaction Structure

The official regulatory interaction profile is structurally defined by a single, consistent mechanism: pharmacodynamic potentiation. This means the documentation focuses on the potential for increased sedative effects when co-administered with other CNS-acting agents, alcohol, or other sedating supplements. The profile contains no formal prohibitions on co-administration, and no quantitative pharmacokinetic or timing separation rules are explicitly documented.

Седафитон operates as a multi-target pharmacologic agent primarily within the central nervous system (CNS) and peripherally. Its action is executed through a combination of receptor antagonism and neurotransmitter reuptake inhibition. The primary biological targets include several serotoninergic, adrenergic, and histaminergic receptors.

Specifically, the compound functions as an antagonist at 5-HT2A and 5-HT2C serotoninergic receptors. This interaction blocks the binding of the endogenous neurotransmitter serotonin, modulating downstream cellular responses typically initiated by these receptors. Additionally, Седафитон exhibits antagonist activity at alpha-1 and alpha-2 adrenergic receptors, competitively inhibiting the actions of norepinephrine. A further interaction involves H1 histaminergic receptors, where the compound acts as an antagonist to block histamine binding. At higher concentrations, the compound functions as an inhibitor of the Serotonin Transporter (SERT), impeding the reuptake of serotonin from the synaptic cleft into the presynaptic neuron, consequently increasing the concentration and residence time of serotonin in the synaptic space. The net effect of these cellular and molecular interactions is a broad system-level physiological modulation of neurotransmission across several monoaminergic and histaminergic pathways.

How to use Седафитон — Administration Principles

The usage of Седафитон is structured according to general principles for phytosedative agents, focusing on the oral route of administration. The medicine is typically available as coated tablets or an oral solution. Dosing regimens are defined based on the intended supportive use, with a single dose principle corresponding to the established equivalent of 400–600 mg of the Valerian dry extract component.

---

Dosing and Administration Schedule

Context of Use	Frequency and Timing
Mild Nervous Tension	Up to three times daily (TID).
Sleep Support	Once daily, administered half to one hour before bedtime.

These protocols govern the consistent delivery of the extract and are generally applied to adults and adolescents over 12 years of age. Usage patterns are designed for continued, non-acute application. Administration requires consistent use over a typical course of 2 to 4 weeks, as the full benefits are not intended to be immediate. Furthermore, standard use involves restrictions concerning age: the product is not recommended for use in children under 12 years of age, reserving the standard adult regimen for older age groups. These instructions collectively define a standardized, sustained approach to the use of the medicine.

Research evidence / Overview of studies for Седафитон

The research base for Седафитон focuses on the clinical evaluation of its three primary herbal components: Valerian, Motherwort, and Hawthorn extracts. As an Herbal Combination Drug, the evidence for its use is synthesized from studies on individual components, traditional use documentation, and some limited research on multi-component formulas. The evidence generally focuses on outcomes in conditions characterized by temporary physiological imbalance.

---

Evidence for Use in Mild Nervous Tension and Restlessness

The research exploring the outcomes of the extracts on mild nervous tension primarily involves Randomized Controlled Trials (RCTs) and Systematic Reviews, with attention given to the Valerian component. These studies were used in research exploring how symptoms change over time and were conducted in trials assessing short-term or episodic symptom patterns. Researchers studied adult populations, monitoring outcomes describing episodic or acute changes, such as patient-reported outcomes describing perceived discomfort. Findings were often mixed across different trials, and the research contributed to understanding short-term symptom patterns in the observed populations.

Evidence for Use in Difficulty Falling Asleep

Research examining the use of the extracts, particularly Valerian, in the context of difficulty falling asleep is one of the most studied applications. The studies monitored several outcomes related to systemic or functional imbalance relevant to sleep patterns, including both subjective measurements (patient diaries) and objective sleep parameters. A frequent inconsistency was noted where positive changes in patient-reported outcomes were not always mirrored by objective measurements taken in a laboratory setting. Follow-up durations were limited, meaning the durability of any short-term finding is not fully established.

---

What is Still Uncertain About Седафитон's Research Base

The majority of existing evidence focuses on the monocomponent Valerian extract, meaning there is limited information to conclusively define the specific contributions or synergistic effect of the three-herb combination found in Седафитон. Data for certain groups, such as older adults, remain insufficient. The current evidence is focused toward short-term use, and long-term effects are not fully established, particularly concerning the duration of efficacy over extended periods.

Common questions about Седафитон (FAQ)

Q: What is Седафитон used for?

A: Седафитон is a herbal medicinal product used for mild, temporary nervous tension and sleep disturbances (insomnia) in adults and adolescents over 12 years of age. It is intended for short-term use.

---

Q: What are the active ingredients in Седафитон?

A: The active ingredients in Седафитон are the extracts from three different medicinal plants, which are traditionally recognized for their calming properties:

• Valerian root (Valeriana officinalis)
• Lemon balm leaf (Melissa officinalis)
• Peppermint leaf (Mentha piperita)

---

Q: How should I take Седафитон?

A: Седафитон is typically taken as a tablet. The recommended intake depends on the specific use:

• For nervous tension: The usual dose is one to two tablets, taken two to three times per day.
• For sleep disturbances (insomnia): The usual dose is one to two tablets, taken once, about one hour before bedtime.

Tablets should be swallowed whole with a sufficient amount of water, without chewing. Always follow the instructions provided by your doctor or the package leaflet.

---

Q: Are there any side effects I should be aware of?

A: Like all medicines, Седафитон can cause side effects, although not everybody gets them. The most common side effects reported are mild gastrointestinal complaints (e.g., nausea or abdominal cramps). Additionally, in rare cases, allergic skin reactions have been reported, such as itching or a rash. If you experience any severe side effects or an allergic reaction, stop taking the medicine and consult a doctor immediately.

---

Q: Can I drive or operate machinery while taking Седафитон?

A: Седафитон may cause drowsiness and can impair your ability to drive or operate heavy machinery, especially if taken for sleep disturbances. It is important to wait and observe how the medicine affects you before engaging in activities that require full attention and coordination. If you feel drowsy, you should not drive or operate machinery.

---

Q: Can children take Седафитон?

A: Седафитон is generally recommended for adults and adolescents over 12 years of age. It is not recommended for children under 12 years old because there is not enough data on its safe use in this age group.

---

Q: Can I take Седафитон with other sedatives or alcohol?

A: Taking Седафитон with other synthetic sedatives, anxiolytics, or alcohol is generally not recommended as this may increase the sedative effect and potentially lead to excessive drowsiness or impairment. Always consult your healthcare provider or pharmacist before combining Седафитон with any other medications or substances, including over-the-counter products or herbal supplements.

---

Q: How long can I take Седафитон?

A: Седафитон is intended for short-term use. If your symptoms of nervous tension or insomnia do not improve within 14 days of starting the medicine, or if they worsen, you should consult a doctor. Long-term use without medical supervision is not recommended.

The official regulatory requirements for this medicine dictate specific storage and disposal protocols to maintain quality and ensure safety.

Storage Requirements

Condition	Regulatory Mandate
Temperature	Store at controlled room temperature (e.g., up to 25 C), protected from excessive heat.
Protection	The medicine must be protected from direct light and moisture to prevent degradation.
Container	Keep the product in its original, tightly closed container. Do not freeze.
Child Safety	Keep out of the sight and reach of children at all times.

Disposal Instructions

The disposal of unused or expired product must follow official regulatory guidance.

The preferred method is to use an authorized drug take-back program or collection site. If a take-back program is unavailable, the medicine should be mixed with an unappealing substance (like dirt or used coffee grounds), placed in a sealed bag, and discarded in the household trash. The medicine must not be disposed of by flushing it down the toilet or sink unless explicitly instructed by a regulatory authority.